Literature DB >> 10981162

Antihypertensive drug therapy in the third millennium: are there benefits beyond blood pressure?

S E Bakir1, S Oparil.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10981162     DOI： 10.1007/s11906-000-0012-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  9 in total

Review 1.  Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

Authors:  J M Wright; C H Lee; G K Chambers
Journal:  CMAJ       Date:  1999-07-13       Impact factor: 8.262

2.  Blood pressure and the risk of cardiovascular disease.

Authors:  S MacMahon
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

3.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

4.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

5.  The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group.

Authors:  P C van den Hoogen; E J Feskens; N J Nagelkerke; A Menotti; A Nissinen; D Kromhout
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

6.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors:  L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

7.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

8.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

Review 9.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012
  9 in total
  1 in total

1.  Postmarketing surveillance study of benazepril in chinese patients with hypertension: An open-label, experimental, epidemiologic study.

Authors:  Jun Lu; Liming Lee; Weihua Cao; Siyan Zhan; Guoying Zhu; Liqiang Dai; Yonghua Hu
Journal:  Curr Ther Res Clin Exp       Date:  2004-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.